Approval · Notice of Compliance 33025 · 2024
LOPERAMIDE-2: Notice of Compliance 33025
Issued April 5, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33025
- Date
- April 5, 2024
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Update Product Monograph to match Licensor
- Canadian reference product
- IMODIUM 2 MG CAPLETS (Janssen Pharmaceutica)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LOPERAMIDE-2 | Not yet assigned | — |
Medicinal ingredients
- LOPERAMIDE HCL 2 MG per TAB